First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.34 USD -2.25% Market Closed
Updated: Apr 27, 2024

ADC Therapeutics SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Revenue Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf14.8m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$371.2m
CAGR 3-Years
709%
CAGR 5-Years
160%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf157.6m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
14%
Idorsia Ltd
SIX:IDIA
Revenue
CHf97.1m
CAGR 3-Years
60%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Revenue
CHf33.6m
CAGR 3-Years
103%
CAGR 5-Years
116%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Revenue?
Revenue
69.6m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Revenue amounts to 69.6m USD.

What is ADC Therapeutics SA's Revenue growth rate?
Revenue CAGR 5Y
129%

Over the last year, the Revenue growth was -67%.